Navigation Links
Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value
Date:2/26/2009

ganizations and suppliers involved in naproxcinod's clinical development and manufacturing activities. At this time, the cost of sales corresponds to the expenses incurred by NicOx in performing research activities under the contracts signed with Pfizer and Merck. On December 31, 2008, the Company employed 97 people in research and development, compared to 84 people at the same date in 2007.

In 2008, administrative and selling expenses totaled EUR11.4 million compared to EUR11.3 million in 2007. General and administrative expenses were EUR6.6 million in 2008 compared to EUR6.8 million in 2007 and include personnel expenses in administrative and financial functions, as well as the remuneration of corporate officers, including stock option, bonus share and warrant attributions. In 2008, selling expenses totaled EUR4.8 million, compared to EUR4.5 million in 2007, and correspond to the market analysis activities for naproxcinod, as well as the business development and communication activities of the Company. The Company anticipates a significant increase in its selling expenses in the future, due to activities linked to the commercial launch preparation for naproxcinod. On December 31, 2008, the Company employed 36 people in its selling, general, and administrative departments, compared to 33 people on December 31, 2007.

Other income

Other income totaled EUR3.8 million in 2008, compared to EUR3.9 million in 2007. Other income corresponds mainly to the operational subsidies from the research tax credits which were previously deducted from research and development expenses until December 31, 2007.

Operating result

In 2008, the operating loss totaled EUR79.2 million, compared to EUR37.2 million in 2007. This situation is explained by the considerable increase in operating expenses during 2008 and by the significant decrease in revenues recognized in 2008 as indicated above.


'/>"/>
SOURCE NicOx
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Arpida Announces Full Year 2008 Financial Results
2. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
3. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
4. American Oriental Bioengineering, Inc. to Report Fourth Quarter and Full Year 2008 Financial Results on March 9, 2009
5. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
6. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
7. CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results
8. Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2008 Financial Results
9. Adolor Corporation to Host Investor Conference Call to Report 2008 Financials and Provide an Update on the Launch of ENTEREG(R) (alvimopan)
10. BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results
11. Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... 20, 2014 HealthTronics, Inc. ... interventional radiology products and services, has signed a ... Clinicon Corporation for its high precision ... of minimally invasive, mobile, surgical technology—offering more choices ... the agreement, HealthTronics will make available Clinicon’s FDA-cleared ...
(Date:9/19/2014)... electricity, to move data would consume much less ... concern as chips, transistor counts rise. , Of ... light emitters, modulators, and detectors emitters are ... for optical chips is molybdenum disulfide (MoS2), which ... single, atom-thick layer. Other experimental on-chip light emitters ...
(Date:9/19/2014)... -- Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology ... to manufacture proteins including biosimilar therapeutics, today announced that ... Annual NewsMakers in the Biotech Industry conference in ... chief executive officer of Pfenex, will provide an overview ... Friday, September 26, 2014 at 10:00 a.m. EDT/7:00 a.m. ...
(Date:9/19/2014)... , The first grants awarded ... Endocrinology (ESPE) Meeting  Investment supports innovative projects ... the field of growth  , EMD Serono, ... , today announced the first recipients of the ... were announced during a Satellite Symposium organized by EMD ...
Breaking Biology Technology:HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3Toward optical chips 2Toward optical chips 3Pfenex to Present at Upcoming Industry Conference on September 26 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3
... the leading,management consulting firm specializing in the pharmaceutical ... Practice will,conduct two workshops at the 44th Drug ... 22 to 26, 2008, at the Boston Convention ... lead a workshop that examines best,practices for accelerated ...
... Xenon,Pharmaceuticals Inc., a drug discovery and development company, ... the Promising Early Stage,Company of the Year Award by ... are delighted to have received this prestigious award, one ... Simon,Pimstone, Xenon,s President and CEO. "This honor is important ...
... The Netherlands, June 17 , - Equens and ... payment processor Equens and supermarket chain Albert Heijn,will begin ... For a period of,six months, customers of Albert Heijn ... fingertips. The objective of the pilot is to,investigate the ...
Cached Biology Technology:Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annual Meeting 2Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annual Meeting 3Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annual Meeting 4Start of First Fingertip Payment Pilot in the Netherlands 2Start of First Fingertip Payment Pilot in the Netherlands 3
(Date:9/19/2014)... thousands of years has adapted to the arctic cold, and ... cold dangerous for you. , This is happening to the ... provoking substance, called nonylphenol, comes from the use of certain ... a endocrine disruptor, but when entering the worm it has ... the cells in its body from cold damage. , ...
(Date:9/18/2014)... PULLMAN, Wash. - Washington State University researchers have developed ... sediment to power waste cleanup in rural areas. ... lead to an inexpensive and quick way to clean ... treatment plants while reducing pollution. , Professor Haluk ... College of Engineering and Architecture discuss the system in ...
(Date:9/18/2014)... Colo., USA Miranda, a small, icy moon of ... enigmatic bodies in the solar system. Despite its relatively ... of intense resurfacing that resulted in the formation of ... polygonal-shaped regions called coronae. , These coronae are ... at least 200 km across. Arden corona, the largest, ...
Breaking Biology News(10 mins):Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3Researchers develop unique waste cleanup for rural areas 2Miranda: An icy moon deformed by tidal heating 2Miranda: An icy moon deformed by tidal heating 3Miranda: An icy moon deformed by tidal heating 4Miranda: An icy moon deformed by tidal heating 5Miranda: An icy moon deformed by tidal heating 6Miranda: An icy moon deformed by tidal heating 7
... WASHINGTON The U.S. Environmental Protection Agency (EPA) ... EPA is releasing a database, called ToxRefDB, which allows ... thousands of toxicity testing results on hundreds of chemicals. ... results. "Tens of thousands of chemicals are in ...
... This release is available in German . 48 ... spray at the start of the experiment, the other half a ... charged situations in the form of a crying child, a girl ... then invited to express the depth of feeling they experienced for ...
... crawla bug that crawls onto your lips while you sleep, ... then gorges on your blood. And if that,s not insult ... potentially deadly disease. Now Jean-Paul Paluzzi, a PhD ... that manipulating physiology to prevent the insects from leaving their ...
Cached Biology News:US Environmental Protection Agency opens access to chemical information 2Hormone spray improves male sensitivity 2The kiss of death: Research targets lethal disease spread by insect that bites lips 2
... HV high-voltage power supply, with temperature probe, 100-120 ... 5,000 V, 500 mA, and 400 W. The ... between 0 and 90 degrees C during electrophoresis. ... Power cord and instructions are provided. Dimensions are ...
... cooling coil, Trans-Blot cell, provides ... high-intensity, and extended electrophoretic transfer ... Trans-Blot cell. Use of the ... to an external water recirculator, ...
... a wide range of next-generation features into ... new standard for flexible laboratory solutions. It ... including pipetting, dilution, dispensing, and integrations ... powerful and flexible as it is efficient ...
... The Biomek FX P is the latest ... design for greater positional accuracy and increased robustness, ... any application. It can be configured with either ... deck capacity, the Biomek FX P sets ...
Biology Products: